CCL2 and diabetes mellitus: Genetic deletion or inhibition of the receptor CCR2 (for a key mediator in the recruitment of inflammatory monocyte chemokine MCP-1) prevented the development of myocardial fibrosis in a model of streptozotocin-induced diabetes [61].